Premature Ejaculation Treatment Market by Drug Type (Selective Serotonin Reuptake Inhibitors (SSRIs) (Dapoxetine, and Others), Phosphodiesterase Type 5 (PDE5) Inhibitors (Zertane, and Others), Topical Anesthetics, and Others), by Route of Administration (Oral and Topical), by Dosage Form (Pills, Spray, and Others), by Distribution Channel (Hospitals, Online Pharmacies, and Retail Pharmacies), and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2026

  • Published On : Jul 2018 |
  • Pages : 190 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Premature Ejaculation Treatment Market- Insights

Ejaculation means discharging of semen from the body. Premature ejaculation (PE) also known as rapid ejaculation, premature climax or early ejaculation is a condition in which the ejaculation happens earlier than a man or his partner would like during a sexual intercourse. The main sign of PE is incapability to delay ejaculation for more than one minute after penetration. Mainly PE can be classified in two types, namely lifelong (primary) PE and acquired (secondary) PE.

Lifelong (primary) PE is a condition, which affects a male lifelong, nearly from the beginning of his first sexual encounter. Acquired (secondary) PE is a condition in which a male who has a normal sex life starts suffering from PE. The actual cause of PE is not known, however, it can caused due to some psychological and biological factors such as early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.

Frequent launches and approvals of novel premature ejaculation treatment products is expected to drive growth of the market

Key players in the market are focusing on launching new products, which in turn is expected to aid in growth of the market. For instance, in 2012, Absorption Pharmaceuticals, LLC launched its Promescent, an over-the-counter lidocaine-based spray, indicated for premature ejaculation. Furthermore, in 2013, Absorption Pharmaceuticals, LLC received patent for its Promescent, for premature ejaculation (PE) from the U.S. Patent and Trademark Office. The launches of novel drugs, which are indicated for the treatment of premature ejaculation is expected to fuel growth of the global premature ejaculation treatment market in the near future.

The global premature ejaculation treatment market size was valued at US$ 1.5 Bn in 2017, and is expected to witness a CAGR of 8.7% over the forecast period (2018 – 2026).

Figure 1. Global Premature Ejaculation Treatment Market Share (%), By Region, 2022

Source: Coherent Market Insights Analysis (2018)

Increasing strategic collaborations for development of new diagnostic tools is expected to propel the market growth

Key players in the market are involved in strategic collaborations for the development of premature ejaculation treatment drugs. For instance, in 2012, Ampio Pharmaceuticals, Inc. entered in a strategic agreement with Ethypharm S.A. for the manufacturing of Zertane, Ampio's drug indicated for the treatment of premature ejaculation. In 2013, Absorption Pharmaceuticals LLC entered into a strategic collaboration with Kaiser Permanente for initiating clinical trial to evaluate the efficacy of Promescent lidocaine spray for men with premature ejaculation (PE). Such strategic collaborations by key players for the development, manufacturing, and evaluation of novel drugs is expected to fuel the global premature ejaculation treatment market growth.

Figure 2. North America Premature Ejaculation Treatment Market Share (%), By Country, 2022

Source: Coherent Market Insights Analysis (2018)

Furthermore, key players are involved in raising funds for the development of drugs and are focused on expanding its sales network, in order to increase their sales. For instance, in 2013, Absorption Pharmaceuticals LLC, a manufacturer of Promescent spray indicated for treatment of premature ejaculation, expanded its international sales team. In 2014, Vyrix Pharmaceuticals, Inc., a subsidiary of Aytu BioScience, raised around US$ 28.75 million. The company financed development of tramadol hydrochloride (Zertane), indicated for the treatment of premature ejaculation from these funds.

Increasing prevalence of premature ejaculation is expected to increase demand for premature ejaculation drugs. For instance, according to the data published by European Association of Urology in 2017, the prevalence rate of premature ejaculation in the U.S. was estimated to be 30% (18-29 years), 32% (30-39 years), 28% (40-49 years), and 55% (50-59 years). According to the same source, the prevalence rate of four sub-types of erectile dysfunction was were 2.3% (lifelong PE), 3.9% (acquired PE), 8.5% (natural variable PE), and 5.1% (premature-like ejaculatory dysfunction). Such high prevalence of premature ejaculation is expected to lead to high demand for its treatment drugs and drive premature ejaculation treatment market growth.

Launch of alternative treatment methods for premature ejaculation is expected to be a major factor, which can restrain the market growth. For instance, in May 2018, InnovaDerma PLC launched a device, Prolong. Prolong is a FDA approved device used in the treatment of premature ejaculation. Launches of such devices is expected to restrain growth of the global premature ejaculation treatment market

Key players operating in the premature ejaculation treatment market include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.

Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.

Market Dynamics

Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.

Key features of the study:

  • This report provides in-depth analysis of premature ejaculation treatment market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global premature ejaculation treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technological up-gradation, market expansion, and marketing tactics
  • The global premature ejaculation treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the premature ejaculation treatment market

Detailed Segmentation:

  • Global Premature Ejaculation Treatment Market, By Drug Type :
    • Selective Serotonin Reuptake Inhibitors (SSRIs)
      • Dapoxetine
      • Others
    • Phosphodiesterase Type 5 (PDE5) Inhibitors
      • Zertane
      • Others
    • Topical Anesthetics
    • Others
  • Global Premature Ejaculation Treatment Market, By Route of Administration:
    • Oral
    • Topical
  • Global Premature Ejaculation Treatment Market, By Dosage Form:
    • Pills
    • Spray
    • Others
  • Global Premature Ejaculation Treatment Market, By Distribution Channel:
    • Hospitals
    • Online Pharmacies
    • Retail Pharmacies
  • Global Premature Ejaculation Treatment Market, By Geography:
    • North America
      • Drug Type:
        • Selective Serotonin Reuptake Inhibitors (SSRIs)
          • Dapoxetine
          • Others
        • Phosphodiesterase Type 5 (PDE5) Inhibitors
          • Zertane
          • Others
        • Topical Anesthetics
        • Others
      • By Route of Administration:
        • Oral
        • Topical
      • By Dosage Form
        • Pills
        • Spray
        • Others
      • By Distribution Channel
        • Hospitals
        • Online Pharmacies
        • Retail Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Europe
      • Drug Type:
        • Selective Serotonin Reuptake Inhibitors (SSRIs)
          • Dapoxetine
          • Others
        • Phosphodiesterase Type 5 (PDE5) Inhibitors
          • Zertane
          • Others
        • Topical Anesthetics
        • Others
      • By Route of Administration:
        • Oral
        • Topical
      • By Dosage Form
        • Pills
        • Spray
        • Others
      • By Distribution Channel
        • Hospitals
        • Online Pharmacies
        • Retail Pharmacies
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Drug Type:
        • Selective Serotonin Reuptake Inhibitors (SSRIs)
          • Dapoxetine
          • Others
        • Phosphodiesterase Type 5 (PDE5) Inhibitors
          • Zertane
          • Others
        • Topical Anesthetics
        • Others
      • By Route of Administration:
        • Oral
        • Topical
      • By Dosage Form
        • Pills
        • Spray
        • Others
      • By Distribution Channel
        • Hospitals
        • Online Pharmacies
        • Retail Pharmacies
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Drug Type:
        • Selective Serotonin Reuptake Inhibitors (SSRIs)
          • Dapoxetine
          • Others
        • Phosphodiesterase Type 5 (PDE5) Inhibitors
          • Zertane
          • Others
        • Topical Anesthetics
        • Others
      • By Route of Administration:
        • Oral
        • Topical
      • By Dosage Form
        • Pills
        • Spray
        • Others
      • By Distribution Channel
        • Hospitals
        • Online Pharmacies
        • Retail Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Drug Type:
        • Selective Serotonin Reuptake Inhibitors (SSRIs)
          • Dapoxetine
          • Others
        • Phosphodiesterase Type 5 (PDE5) Inhibitors
          • Zertane
          • Others
        • Topical Anesthetics
        • Others
      • By Route of Administration:
        • Oral
        • Topical
      • By Dosage Form
        • Pills
        • Spray
        • Others
      • By Distribution Channel
        • Hospitals
        • Online Pharmacies
        • Retail Pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Drug Type:
        • Selective Serotonin Reuptake Inhibitors (SSRIs)
          • Dapoxetine
          • Others
        • Phosphodiesterase Type 5 (PDE5) Inhibitors
          • Zertane
          • Others
        • Topical Anesthetics
        • Others
      • By Route of Administration:
        • Oral
        • Topical
      • By Dosage Form
        • Pills
        • Spray
        • Others
      • By Distribution Channel
        • Hospitals
        • Online Pharmacies
        • Retail Pharmacies
      • By Country:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Regent Pacific Group Limited *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Menarini Group
    • Furiex Pharmaceuticals, Inc.
    • Absorption Pharmaceuticals, LLC
    • Ampio Pharmaceuticals, Inc.
    • Aytu BioScience
    • NeuroHealing Pharmaceuticals Inc.
    • Dong-A Pharmaceutical Co., Ltd.

*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Route of Administration
      • Market Snippet, By Dosage Form
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • PEST Analysis
    • Pipeline Analysis
    • Product Approval
    • Product Launch
    • Collaboration-Acquisition
    • Porter’s Five Forces Analysis
  4. Global Premature Ejaculation Treatment Market, By Drug Type, 2016 – 2026 (US$ Bn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Selective Serotonin Reuptake Inhibitors (SSRIs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
      • Segment Trends
        • Dapoxetine
        • Others
    • Phosphodiesterase Type 5 (PDE5) Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
      • Segment Trends
        • Zertane
        • Others
    • Topical Anesthetics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
  5. Global Premature Ejaculation Treatment Market, By Route of Administration, 2016 – 2026 (US$ Bn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
  6. Global Premature Ejaculation Treatment Market, Dosage Form, 2016 – 2026 (US$ Bn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Pills
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
    • Spray
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
  7. Global Premature Ejaculation Treatment Market, By Distribution Channel, 2016 – 2026 (US$ Bn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
  8. Global Premature Ejaculation Treatment Market, By Region, 2016 – 2026 (US$ Bn)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Bn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
  9. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Regent Pacific Group Limited
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Menarini Group
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Furiex Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Absorption Pharmaceuticals, LLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Ampio Pharmaceuticals, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Aytu BioScience
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • NeuroHealing Pharmaceuticals Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Dong-A Pharmaceutical Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 37 market data tables and 40 figures on “Premature Ejaculation Treatment Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.